JECIX Performance — Mid Cap Index Trust, Series I
Data updated: 2026-08-27
JECIX returned +17.05% year to date and +25.28% over one year to Jun 2026. Annualised returns are +14.86% over 3 years and +8.57% over 5 years. The fund beat its US Mid-Cap Blend category average: $100 invested three years ago grew to $152, against $150 for the category, and to $125 over one year, against $122. Volatility over the past three years was 15.85% a year. In the 12 months to Jun 2026 the fund lost a net $49.9M, and assets reached $1.31B.
JECIX Growth of $100
What $100 invested in Mid Cap Index Trust grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Blend category average over the same months.
| Period | JECIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $125 | $122 |
| 3 years (Jul 2023 – Jun 2026) | $152 | $150 |
| 5 years (Jul 2021 – Jun 2026) | $151 | $147 |
| Since data start (Jul 2019 – Jun 2026) | $214 | $208 |
JECIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +17.05% |
| 1 year | +25.28% |
| 3 years (annualised) | +14.86% |
| 5 years (annualised) | +8.57% |
JECIX Annual Returns
Calendar-year total returns of Mid Cap Index Trust, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +17.05% |
| 2025 | +6.97% |
| 2024 | +13.35% |
| 2023 | +16.02% |
| 2022 | −13.43% |
| 2021 | +24.21% |
| 2020 | +13.22% |
| 2019 (Jul–Dec) | +6.71% |
JECIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.0% | +4.1% | −5.4% | +7.8% | +2.4% | +3.5% | — | — | — | — | — | — |
| 2025 | +3.8% | −4.4% | −5.5% | −2.3% | +5.4% | +3.5% | +1.6% | +3.3% | +0.4% | −0.5% | +2.0% | 0.0% |
| 2024 | −1.8% | +5.9% | +5.5% | −6.0% | +4.3% | −1.6% | +5.8% | −0.1% | +1.1% | −0.7% | +8.7% | −7.2% |
| 2023 | +9.2% | −1.8% | −3.2% | −0.8% | −3.3% | +9.2% | +4.1% | −2.9% | −5.3% | −5.4% | +8.5% | +8.7% |
| 2022 | −7.2% | +1.1% | +1.3% | −7.1% | +0.7% | −9.6% | +10.8% | −3.2% | −9.2% | +10.5% | +6.0% | −5.6% |
| 2021 | +1.5% | +6.7% | +4.6% | +4.5% | +0.2% | −1.0% | +0.3% | +1.9% | −4.0% | +5.9% | −3.0% | +5.0% |
| 2020 | −2.6% | −9.6% | −20.2% | +14.2% | +7.2% | +1.2% | +4.6% | +3.5% | −3.3% | +2.1% | +14.2% | +6.4% |
| 2019 | — | — | — | — | — | — | +1.1% | −4.2% | +3.0% | +1.1% | +2.9% | +2.7% |
JECIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 15.85%
- 3-year Sharpe ratio: 0.65 (vs 4.5% risk-free rate)
- Best month: +8.74% (Nov 2024)
- Worst month: −7.16% (Dec 2024)
JECIX Fund Flows
Monthly money in and out of Mid Cap Index Trust, from SEC Form N-PORT.
- 12-month net flow: −$49.9M
- 12-month gross sales (incl. reinvestments): $129.7M
- Sales ÷ redemptions: 0.72×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $4.2M | $11.9M | −$7.7M |
| May 2026 | $2.8M | $9.1M | −$6.3M |
| Apr 2026 | $1.1M | $13.9M | −$12.8M |
| Mar 2026 | $2.9M | $11.8M | −$8.9M |
| Feb 2026 | $400K | $15.1M | −$14.7M |
| Jan 2026 | $3.4M | $17.9M | −$14.5M |
| Dec 2025 | $4.0M | $12.1M | −$8.2M |
| Nov 2025 | $2.4M | $14.7M | −$12.3M |
| Oct 2025 | $100.3M | $19.3M | $81.0M |
| Sep 2025 | $1.7M | $14.8M | −$13.1M |
| Aug 2025 | $4.0M | $10.1M | −$6.1M |
| Jul 2025 | $2.6M | $28.9M | −$26.3M |
JECIX Assets Under Management
Net assets of Mid Cap Index Trust by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.31B |
| 2026-03-31 | $1.17B |
| 2025-12-31 | $1.18B |
| 2025-09-30 | $1.20B |
| 2025-06-30 | $1.18B |
| 2025-03-31 | $1.13B |
| 2024-12-31 | $1.25B |
| 2024-09-30 | $1.28B |
| 2024-06-30 | $1.22B |
| 2024-03-31 | $1.30B |
| 2023-12-31 | $1.22B |
| 2023-09-30 | $1.11B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.